Genomic and transcriptomic analysis of imatinib resistance in gastrointestinal stromal tumors
about
A Novel Receptor Tyrosine Kinase Switch Promotes Gastrointestinal Stromal Tumor Drug Resistance.ETV4 collaborates with Wnt/β-catenin signaling to alter cell cycle activity and promote tumor aggressiveness in gastrointestinal stromal tumor.Combinatory use of distinct single-cell RNA-seq analytical platforms reveals the heterogeneous transcriptome response.Establishment of a GIST-T1 gastrointestinal stromal tumour cell line resistant to imatinib mesylate.
P2860
Genomic and transcriptomic analysis of imatinib resistance in gastrointestinal stromal tumors
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genomic and transcriptomic ana ...... astrointestinal stromal tumors
@en
Genomic and transcriptomic ana ...... strointestinal stromal tumors.
@nl
type
label
Genomic and transcriptomic ana ...... astrointestinal stromal tumors
@en
Genomic and transcriptomic ana ...... strointestinal stromal tumors.
@nl
prefLabel
Genomic and transcriptomic ana ...... astrointestinal stromal tumors
@en
Genomic and transcriptomic ana ...... strointestinal stromal tumors.
@nl
P2093
P2860
P4510
P50
P356
P1476
Genomic and transcriptomic ana ...... astrointestinal stromal tumors
@en
P2093
Asmaa Elzawahry
Eisaku Furukawa
Hiromi Nakamura
Katsuya Tsuchihara
Rie Nakatsuka
Sachiyo Mimaki
Seiichi Hirota
Takahiko Nishigaki
Tatsuhiro Shibata
Toshirou Nishida
P2860
P304
P356
10.1002/GCC.22438
P577
2016-12-20T00:00:00Z